Matches in DBpedia 2014 for { <http://dbpedia.org/resource/BioMarin_Pharmaceutical> ?p ?o. }
Showing items 1 to 74 of
74
with 100 items per page.
- BioMarin_Pharmaceutical abstract "BioMarin Pharmaceutical Inc. is a biotechnology firm based in Novato, California. It has offices and facilities in the US, South America, Asia and Europe. BioMarin develops and commercializes innovative biopharmaceuticals for serious, life-threatening rare diseases and medical conditions. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin is the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). BioMarin is also the first company to provide therapeutics for Phenylketonuria (PKU).".
- BioMarin_Pharmaceutical assets "1.6".
- BioMarin_Pharmaceutical equity "1.02".
- BioMarin_Pharmaceutical foundingYear "1997".
- BioMarin_Pharmaceutical industry Biotechnology.
- BioMarin_Pharmaceutical locationCity Novato,_California.
- BioMarin_Pharmaceutical locationCountry United_States.
- BioMarin_Pharmaceutical numberOfEmployees "1100".
- BioMarin_Pharmaceutical operatingIncome "-109.0".
- BioMarin_Pharmaceutical product 3,4-Diaminopyridine.
- BioMarin_Pharmaceutical product Arylsulfatase_B.
- BioMarin_Pharmaceutical product Iduronidase.
- BioMarin_Pharmaceutical product Tetrahydrobiopterin.
- BioMarin_Pharmaceutical revenue "501.0".
- BioMarin_Pharmaceutical type Public_company.
- BioMarin_Pharmaceutical wikiPageExternalLink www.bmrn.com.
- BioMarin_Pharmaceutical wikiPageID "4136144".
- BioMarin_Pharmaceutical wikiPageRevisionID "603006225".
- BioMarin_Pharmaceutical assets "US$1.6B".
- BioMarin_Pharmaceutical equity "US$1.02B".
- BioMarin_Pharmaceutical footnotes ";".
- BioMarin_Pharmaceutical foundation "1997".
- BioMarin_Pharmaceutical hasPhotoCollection BioMarin_Pharmaceutical.
- BioMarin_Pharmaceutical homepage www.bmrn.com.
- BioMarin_Pharmaceutical industry Biotechnology.
- BioMarin_Pharmaceutical keyPeople "Dan Spiegelman, Chief Financial Officer".
- BioMarin_Pharmaceutical keyPeople "Henry J. Fuchs, Chief Medical Officer".
- BioMarin_Pharmaceutical keyPeople "Jean-Jacques Bienaime, Chief Executive Officer".
- BioMarin_Pharmaceutical locationCity Novato,_California.
- BioMarin_Pharmaceutical locationCountry United_States.
- BioMarin_Pharmaceutical logo "220".
- BioMarin_Pharmaceutical name "BioMarin Pharmaceutical Inc.".
- BioMarin_Pharmaceutical numEmployees "1100".
- BioMarin_Pharmaceutical operatingIncome "US$-109M".
- BioMarin_Pharmaceutical products 3,4-Diaminopyridine.
- BioMarin_Pharmaceutical products Arylsulfatase_B.
- BioMarin_Pharmaceutical products Iduronidase.
- BioMarin_Pharmaceutical products Tetrahydrobiopterin.
- BioMarin_Pharmaceutical revenue "US$501M".
- BioMarin_Pharmaceutical type Public_company.
- BioMarin_Pharmaceutical subject Category:Biotechnology_companies_of_the_United_States.
- BioMarin_Pharmaceutical subject Category:Companies_in_the_NASDAQ_Biotechnology_Index.
- BioMarin_Pharmaceutical subject Category:Companies_listed_on_NASDAQ.
- BioMarin_Pharmaceutical subject Category:Novato,_California.
- BioMarin_Pharmaceutical subject Category:Technology_companies_based_in_the_San_Francisco_Bay_Area.
- BioMarin_Pharmaceutical type Abstraction100002137.
- BioMarin_Pharmaceutical type BiotechnologyCompanies.
- BioMarin_Pharmaceutical type CompaniesInTheNASDAQBiotechnologyIndex.
- BioMarin_Pharmaceutical type CompaniesListedOnNASDAQ.
- BioMarin_Pharmaceutical type Company108058098.
- BioMarin_Pharmaceutical type Group100031264.
- BioMarin_Pharmaceutical type Institution108053576.
- BioMarin_Pharmaceutical type Organization108008335.
- BioMarin_Pharmaceutical type SocialGroup107950920.
- BioMarin_Pharmaceutical type YagoLegalActor.
- BioMarin_Pharmaceutical type YagoLegalActorGeo.
- BioMarin_Pharmaceutical type YagoPermanentlyLocatedEntity.
- BioMarin_Pharmaceutical type Agent.
- BioMarin_Pharmaceutical type Company.
- BioMarin_Pharmaceutical type Organisation.
- BioMarin_Pharmaceutical type Organization.
- BioMarin_Pharmaceutical type Agent.
- BioMarin_Pharmaceutical type SocialPerson.
- BioMarin_Pharmaceutical type Thing.
- BioMarin_Pharmaceutical comment "BioMarin Pharmaceutical Inc. is a biotechnology firm based in Novato, California. It has offices and facilities in the US, South America, Asia and Europe. BioMarin develops and commercializes innovative biopharmaceuticals for serious, life-threatening rare diseases and medical conditions. BioMarin's core business and research is in enzyme replacement therapies (ERTs).".
- BioMarin_Pharmaceutical label "BioMarin Pharmaceutical".
- BioMarin_Pharmaceutical sameAs m.0bl0xp.
- BioMarin_Pharmaceutical sameAs Q4914632.
- BioMarin_Pharmaceutical sameAs Q4914632.
- BioMarin_Pharmaceutical sameAs BioMarin_Pharmaceutical.
- BioMarin_Pharmaceutical wasDerivedFrom BioMarin_Pharmaceutical?oldid=603006225.
- BioMarin_Pharmaceutical homepage www.bmrn.com.
- BioMarin_Pharmaceutical isPrimaryTopicOf BioMarin_Pharmaceutical.
- BioMarin_Pharmaceutical name "BioMarin Pharmaceutical Inc.".